StockNYSECRL
Charles River Laboratories
$353.66
+14.96 (+4.42%)today
Valuation & earnings
- P/E ratio
- 384.41
- Forward P/E
- 27.31
- EPS (ttm)
- $0.92
- Forward EPS
- $12.95
- Price/book
- 5.25
- PEG ratio
- 0.12
- Dividend yield
- 0%
- Payout ratio
- 0%
Financials (ttm)
- Revenue (ttm)
- 4B
- Revenue growth
- -2.2%
- Profit margin
- 1.01%
- Return on equity
- 1.27%
- Total cash
- 200.4M
- Total debt
- 2.9B
Earnings (EPS)
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| Dec 31, 2025 | 2.35 | 2.39 | +1.91% |
| Mar 31, 2026 | 1.95 | 2.06 | +5.42% |
| Jun 30, 2026 | 2.74 | 3.02 | +10.31% |
| Sep 30, 2026 | 2.98 | 3.09 | +3.55% |
Next earnings date: Nov 4, 2026
Analyst view
Consensus ratingBuy17 analysts
Strong buy 3Buy 11Hold 2Sell 1
12-month price targetsImplied upside: -1.32%
145
349
400
LowCurrent priceHigh
Related products
How visible is Charles River Laboratories in AI search?
We ask AI search engines about Charles River Laboratories and its market — live — and measure whether and how prominently the brand appears in their answers.
No AI visibility check has been run for Charles River Laboratories yet.
Run a live check to see how AI search engines talk about this brand right now.
Is your brand this visible in AI search?
Aurora tracks your brand across 7 AI search engines — visibility, share of voice and the sources that shape AI answers.